Learn More
RESEARCH DESIGN AND METHODS — Main inclusion criteria were patients aged 18 years with type 2 diabetes and A1C 7.5 and 10.0% (diet) or 7.0 and 9.5% (mono–oral antidiabetes drug); previous therapy was(More)
AIMS To assess the effect of liraglutide, a once-daily human glucagon-like peptide-1 analogue on pancreatic B-cell function. methods: Patients with Type 2 diabetes (n = 39) were randomized to(More)
  • 1